Avioq CLx-Series Media
• Avioq Reagent Introduction & Principle of Assay
For more information please email us at: infor@avioq.com
• Avioq Reagent Introduction & Principle of Assay
For more information please email us at: infor@avioq.com
No job openings at this time.
Thank you.
————————–
This link leads to the machine readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.
https://www.bluecrossnc.com/about-us/policies-and-best-practices/transparency-coverage-mrf#
For more information please email us at: infor@avioq.com
Technology Highlights
• Principle: Glow Chemiluminescence based on Alkaline Phosphatase (ALP)
• Separation: Magnetic Microbeads
• FITC/anti-FITC connected bridge
• Innovative Substrate
• 6 point calibration Curve (Master) with 2 point calibration
Avioq Announces CE Mark and European Launch of VioOne HIV Profile Supplemental Assay
Avioq Announces Health Canada Approval and Canadian Launch of HTLV-I/II Test
Avioq Announces CE Mark and European Launch of HTLV-I/II Test
Avioq Announces FDA Approval for HTLV-I/II Microelisa System